Press release
Why the Liver Cancer Screening Market is set to explode? Top Companies: Illumina, Inc., Thermo Fisher Scientific Inc., Abbott, Danaher, Siemens Healthcare GmbH and more
The American Society for Clinical Oncology (ASCO) states that approximately 42,220 adults were suffering from primary liver cancer in the U.S. Out of those, an estimated 30,610 were men and 11,610 were women.
ASCO further declared that since 1980, the rates of liver cancer have tripled. This information is published in an upcoming report by Fortune Business Insights, titled, “Liver Cancer Screening Market Size, Share and Global Trend By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy), By End User (Hospitals, Oncology Clinics, Diagnostics Centers) and Geography Forecast till 2026.”
Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/liver-cancer-screening-market-101175
The report provides elaborate data regarding the global liver cancer screening market segmentation, followed by market share. Additionally, the report offers details about the latest developments happening in the industry. It further showcases in-depth information about the ongoing trends and regional analysis.
Fortune Business Insights has listed some of the prominent market players operating in the liver cancer screening market. They are as follows:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Abbott
• Danaher
• Siemens Healthcare GmbH
• F. Hoffmann-La Roche Ltd
• Sysmex Corporation
• Biocept, Inc.
• Foundation Medicine, Inc.
Other key market players
Rise in Demand for Preventive Care for Diagnostic Examinations to Favor Growth in North America
The global liver cancer screening market is geographically divided into the Middle East & Africa, North America, Asia Pacific, Europe, and Latin America. Amongst these, North America is in the dominant position and it currently holds the highest global cancer screening market share. The growth is attributed to the rising incidence of liver cancer, increasing demand for preventive care by diagnostic examinations, and high healthcare expenditure. Additionally, increasing awareness programs regarding liver cancer, easy access to advanced treatment options, increasing investments by key market players for the development of early diagnostic options, and well-established healthcare infrastructure are likely to fuel the liver cancer screening market growth in this region.
Asia Pacific, on the other hand, is considered to be one of the fastest growing markets due to a rise in the prevalence of cancer. Moreover, expansion of healthcare infrastructure, greater disposable income, increasing demand for technologically advanced diagnostics, and high patient pool are expected to boost liver cancer screening market growth in this region.
Get Sample PDF Brochure at
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/liver-cancer-screening-market-101175
Epigenomics and Oncimmune Aim to Increase Sales through Technologically Advanced Product Launches
The Johns Hopkins University of Johns Hopkins Health System Corporation announced that it received the biggest A Series investment for CancerSEEK in June 2019. CancerSEEK is a liquid biopsy test that is specially designed for detecting various cancer types at the initial stages of the disease. Thrive Earlier Detection Corp., a developer of cancer detecting tests, based in Cambridge, is currently developing CancerSEEK with the help of $110 million funding. According to the company, CancerSEEK will be a blood-based test that would be cost-effective and would be used as part of regular medical care. The test will serve as a resource to support those patients and their families who are often confused and overwhelmed following a cancer diagnosis.
Epigenomics AG, a molecular diagnostics company, based in Berlin, announced the launch of its blood test called mSEPT9 in July 2018. In a clinical study, mSEPT9 exhibited more diagnostic accuracy than the already established diagnostic marker. It also surpassed alpha-fetoprotein (AFP), a widely used diagnostic marker. According to the company, an accurate blood test will have the capacity to monitor those patients who are at high risk for suffering from liver cancer.
Oncimmune Holdings plc, a cancer detection test provider, headquartered in the U.K., announced the launch of EarlyCDT-Liver test in May 2018. It would be used for hepatocellular carcinoma (HCC) and will be available commercially in the U.S. The test has a specificity of 97%. It is the second test delivered by Oncimmune after EarlyCDT-Lung test. The platform has the ability to detect cancer up to four years earlier. According to the company, the EarlyCDT-Liver test is complementary to diagnosis of cancer via imaging. It is a simple blood test. It further aids in early detection of HCC in patients. Overall, prominent key players are focusing on innovative product launches to gain competitive edge in the global cancer screening market.
Speak To Analyst at
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/liver-cancer-screening-market-101175
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
ASCO further declared that since 1980, the rates of liver cancer have tripled. This information is published in an upcoming report by Fortune Business Insights, titled, “Liver Cancer Screening Market Size, Share and Global Trend By Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma), By Screening (Laboratory Testing, Imaging, Endoscopy, Biopsy), By End User (Hospitals, Oncology Clinics, Diagnostics Centers) and Geography Forecast till 2026.”
Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/liver-cancer-screening-market-101175
The report provides elaborate data regarding the global liver cancer screening market segmentation, followed by market share. Additionally, the report offers details about the latest developments happening in the industry. It further showcases in-depth information about the ongoing trends and regional analysis.
Fortune Business Insights has listed some of the prominent market players operating in the liver cancer screening market. They are as follows:
• Illumina, Inc.
• Thermo Fisher Scientific Inc.
• Abbott
• Danaher
• Siemens Healthcare GmbH
• F. Hoffmann-La Roche Ltd
• Sysmex Corporation
• Biocept, Inc.
• Foundation Medicine, Inc.
Other key market players
Rise in Demand for Preventive Care for Diagnostic Examinations to Favor Growth in North America
The global liver cancer screening market is geographically divided into the Middle East & Africa, North America, Asia Pacific, Europe, and Latin America. Amongst these, North America is in the dominant position and it currently holds the highest global cancer screening market share. The growth is attributed to the rising incidence of liver cancer, increasing demand for preventive care by diagnostic examinations, and high healthcare expenditure. Additionally, increasing awareness programs regarding liver cancer, easy access to advanced treatment options, increasing investments by key market players for the development of early diagnostic options, and well-established healthcare infrastructure are likely to fuel the liver cancer screening market growth in this region.
Asia Pacific, on the other hand, is considered to be one of the fastest growing markets due to a rise in the prevalence of cancer. Moreover, expansion of healthcare infrastructure, greater disposable income, increasing demand for technologically advanced diagnostics, and high patient pool are expected to boost liver cancer screening market growth in this region.
Get Sample PDF Brochure at
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/liver-cancer-screening-market-101175
Epigenomics and Oncimmune Aim to Increase Sales through Technologically Advanced Product Launches
The Johns Hopkins University of Johns Hopkins Health System Corporation announced that it received the biggest A Series investment for CancerSEEK in June 2019. CancerSEEK is a liquid biopsy test that is specially designed for detecting various cancer types at the initial stages of the disease. Thrive Earlier Detection Corp., a developer of cancer detecting tests, based in Cambridge, is currently developing CancerSEEK with the help of $110 million funding. According to the company, CancerSEEK will be a blood-based test that would be cost-effective and would be used as part of regular medical care. The test will serve as a resource to support those patients and their families who are often confused and overwhelmed following a cancer diagnosis.
Epigenomics AG, a molecular diagnostics company, based in Berlin, announced the launch of its blood test called mSEPT9 in July 2018. In a clinical study, mSEPT9 exhibited more diagnostic accuracy than the already established diagnostic marker. It also surpassed alpha-fetoprotein (AFP), a widely used diagnostic marker. According to the company, an accurate blood test will have the capacity to monitor those patients who are at high risk for suffering from liver cancer.
Oncimmune Holdings plc, a cancer detection test provider, headquartered in the U.K., announced the launch of EarlyCDT-Liver test in May 2018. It would be used for hepatocellular carcinoma (HCC) and will be available commercially in the U.S. The test has a specificity of 97%. It is the second test delivered by Oncimmune after EarlyCDT-Lung test. The platform has the ability to detect cancer up to four years earlier. According to the company, the EarlyCDT-Liver test is complementary to diagnosis of cancer via imaging. It is a simple blood test. It further aids in early detection of HCC in patients. Overall, prominent key players are focusing on innovative product launches to gain competitive edge in the global cancer screening market.
Speak To Analyst at
https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/liver-cancer-screening-market-101175
Contact Us:
Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com
About Us:
Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.
Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.
At Fortune Business Insights, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage
to this press release on woodPRI. woodPRI disclaims liability for any content contained in
this release.
Recommend
/newsMicroencapsulation Market Deep Analysis on Key Players - Dow Corning, Encapsys, Syngenta Crop Protection, Evonik Industries, 3M and Bayer
Market Study Report Adds Global Microencapsulation Market Size, Status and Forecast 2024 added to its database. The report provides key statistics on the current state of the industry and other analytical data to understand the market.
Extensive research is required for choosing the appropriate cor...
/newsGermany Airbag Market Size 2023: Global Share, Industry And Report Analysis By 2030 | Hyundai Mobis Co., Ltd. Key Safety Systems, Inc. Robert Bosch GmbH
Germany airbag market is expected to grow at a CAGR of around 6% during the forecast period. Germany Airbag Market research report refers to gathering and analyzing significant market data serve as best medium for various industry players to launch novel product or service. It is vital for key firms...
/newsSecurities Brokerages And Stock Exchanges Market Outlook 2021: Big Things are Happening
A new intelligence report released by HTF MI with title "Global Securities Brokerages And Stock Exchanges Market Survey & Outlook" is designed covering micro level of analysis by Insurers and key business segments, offerings and sales channels. The Global Securities Brokerages And Stock Exchange...
/newsRenewable Chemicals Market Emerging Trends and Competitive Landscape Forecast to 2028
The renewable chemicals market was valued at US$ 80,566.30 million in 2021 and is projected to reach US$ 1,76,750.76 million by 2028 it is expected to grow at a CAGR of 11.9% from 2021 to 2028. The research report focuses on the current market trends, opportunities, future potential of the market, a...
/newsHow Coronavirus is Impacting Cold Brew Coffee, Global Market Volume Analysis, Size, Share and Key Trends 2020-2026
"Market Latest Research Report 2020:
Los Angles United States, February 2020: The Cold Brew Coffee market has been garnering remarkable momentum in the recent years. The steadily escalating demand due to improving purchasing power is projected to bode well for the global market. QY Research's lates...
/newsCorporate E-Learning Market - Global Industry Size, Share, Key Players Analysis that are Infor, SkillSoft Corporation, Adrenna, CERTPOINT Systems and others with Regional Forecast to 2022
Overview:
E-Learning is used to enhance the learning procedures for newer job requirements and to make employees sound about the internal and external changes in the market and respective organizations. This method has created considerable differences in the ways of training and developing employee...
